Filing Details

Accession Number:
0001140361-19-018071
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-10-07 19:15:59
Reporting Period:
2019-10-07
Accepted Time:
2019-10-07 19:15:59
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1781983 Aprea Therapeutics Inc. APRE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1608536 M Scott Coiante 535 Boylston Street
Boston MA 02116
Svp, Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2019-10-07 2,500 $15.00 2,500 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to Buy) Acquisiton 2019-10-07 150,824 $0.00 150,824 $15.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
150,824 2029-10-02 No 4 A Direct
Footnotes
  1. Twenty-five percent of these options vest on October 2, 2020, with the remaining options vesting ratably over the following 36 months, subject to the reporting person's continued employment through and including the applicable vesting date and subject to acceleration under certain conditions.